Improving protein therapies using advanced technology and machine learning.
Unsupervised optimization of protein therapeutics using closed-loop in vitro synthesis, nanosensing, and deep-learning
['FUNDING_OTHER'] · IOWA STATE UNIVERSITY · NIH-10894155
This study is working on new ways to make better protein-based treatments for patients, using cool technology to create therapies that are more effective and personalized just for you.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | IOWA STATE UNIVERSITY (nih funded) |
| Locations | 1 site (AMES, UNITED STATES) |
| Trial ID | NIH-10894155 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative materials and methods to enhance the production and effectiveness of protein-based therapies. By utilizing advanced optical nanosensors, cell-free protein synthesis techniques, and machine learning algorithms, the project aims to streamline the design and manufacturing processes for biological products. Patients may benefit from improved therapies that are more effective and tailored to their specific conditions, as the research seeks to overcome current limitations in protein therapy development.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could be treated or improved by novel protein therapies.
Not a fit: Patients with conditions that do not respond to protein-based therapies may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized protein-based therapies for various diseases.
How similar studies have performed: Other research has shown success in using machine learning and advanced biomanufacturing techniques to improve therapeutic outcomes, indicating a promising direction for this project.
Where this research is happening
AMES, UNITED STATES
- IOWA STATE UNIVERSITY — AMES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: REUEL, NIGEL F — IOWA STATE UNIVERSITY
- Study coordinator: REUEL, NIGEL F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.